| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222892 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Mediastinal IMRT after doxorubicin-based chemotherapy can be safely and efficiently delivered, and it provides favorable outcomes in PMBCL patients with a large target volume and high-risk features.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Li-Ming MD, Ye-Xiong MD, Hui MD, Jing MD, Wei-Hu MD, Shu-Lian MD, Yue-Ping MD, Yong-Wen MD, Qing-Feng MD, Bo MD, Shu-Nan MD, Hua MD, Jian-Rong PhD,